Overview
Lobbying Costs
50,000€ - 99,999€
Financial year: Jan 2022 - Dec 2022
Lobbyists (Full time equivalent)
2 Fte (8)
Lobbyists with EP accreditation
0
High-level Commission meetings
1
Lobbying Costs over the years
-
Info
PHARMIG - Verband der pharmazeutischen Industrie Österreichs (PHARMIG)
EU Transparency Register
098025935611-30 First registered on 09 Aug 2019
Goals / Remit
Die PHARMIG, Verband der pharmazeutischen Industrie Österreichs, ist die freiwillige, parteipolitisch unabhängige Interessenvertretung der Pharmaindustrie in Österreich. Die rund 120 Mitgliedsunternehmen mit ca. 18.000 Mitarbeitern decken den heimischen Arzneimittelmarkt zu gut 95 % ab.
Die Pharmig und ihre Mitgliedsfirmen stehen für eine bestmögliche Versorgungssicherheit mit Arzneimitteln im Gesundheitswesen und sichern durch Qualität und Innovation den gesellschaftlichen und medizinischen Fortschritt.
Die pharmazeutische Industrie setzt sich für die Stärkung des Forschungs- und Pharmastandortes Österreich ein. Sie ist damit ein herausragendes Beispiel für die erfolgreiche Zusammenarbeit zwischen Wirtschaft und Wissenschaft, die letztlich der Weiterentwicklung unserer Wissensgesellschaft dient.
Die Pharmig unterstützt als anerkannter und kompetenter Partner mit hoher Fachexpertise die Entscheidungsträger im Gesundheitswesen sowie relevante Politikbereiche.
Dabei fordert di (...)Main EU files targeted
pharmazeutische Gesetzgebung und Initiativen generell; aktuell insbesondere:
Evaluation and Revision of the EU's general pharmaceutical legislation (as part of the EU Pharma Strategy);
Reg. (EU) Nr. 536/2014 (clinical trials);
EudraLex Vol.4 Annex 1 (manufacture of sterile medicinal products);
EudraLex Vol.4 Annex 21 (Import);
Reg. (EU) 469/2009 (supplementary protection certificate for medicinal products) & SPC Export Waiver;
Dir. on Urban Waste Water Treament & EU's strategic approach to pharmaceuticals in the environment;
CSRD;
CSDDD;
Proposal for a regulation on health technology assessment (HTA) and amending directive 2011/24/EU;
Delegated Reg. (EU) 2016/161 supplementing Dir. 2001/83/EG;
Reg. (EU) 2022/123 (EMA extended mandate);
Reg. on the European Health Data Space;
Product Liability Reg.
Artifical Intelligence Liablity Reg.
Directive on Representative ActionsAddress
Head Office
Operngasse 6/6
Wien 1010
AUSTRIAEU Office
Operngasse 6/6
Wien 1010
AUSTRIAWebsite
-
People
Total lobbyists declared
8
Employment time Lobbyists 25% 8 Lobbyists (Full time equivalent)
2
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
Erarbeitung von Positionen auf österreichischer Ebene zu Themen in Rubrik 9. In diesem Zusammenhang Abstimmung/Vernetzung auf EU-Ebene mit EFPIA (European Federation of Pharmaceutical Industries and Associations).
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Trade and business associations
-
Networking
Affiliation
Mitgliedschaft bei der IFPMA (International Federation of Pharmaceutical Manufacturers & Associations)
Unterstützung weiterer Organisationen sind auf der Homepage unter Transparenz aufgelistet (pro Kalenderjahr): https://www.pharmig.at/pharmaindustrie/transparenz/Member organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2022 - Dec 2022
Lobbying costs for closed financial year
50,000€ - 99,999€
Major contributions in closed year
None declared
Intermediaries for closed year
None declaredIntermediaries for current year
None declaredClosed year Costs
50,000€ - 99,999€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
Gremienarbeit; Stakeholder-Gespräche; Stellungnahmen; nationale Umsetzung; Aussendungen
Other activities
None declared
Meetings
Meetings
1 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 28 Jul 2022 Location Salzburg, Austria Subject Current economic and geopolitical challenges. European strategic autonomy. Consequences of Covid-19 for European health policy. Cabinet Cabinet of Commissioner Johannes Hahn Portfolio Budget and Administration Attending - Barbara Herbolzheimer (Cabinet member)
- Johannes Hahn (Commissioner)
Other Lobbyists